Eli Lilly CDR (CAD Hedged)

LLY•Toronto Stock Exchange

Canada

Need professional-grade analysis? Visit stockanalysis.com

CA$33.70

+5.64%

End of day

Market Cap

$1.04T

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	-1.05	-1.22	-0.73	—	—	-0.97
Calmar	—	-3.11	-1.68	-0.84	—	—	-1.63
Sharpe	—	-0.63	-0.80	-0.49	—	—	-0.62
Omega	—	0.88	0.86	0.93	—	—	0.89
Martin	—	-6.37	-2.69	-1.69	—	—	-3.06
Ulcer	—	3.73	13.01	10.64	—	—	9.90

Eli Lilly CDR (CAD Hedged) (LLY) Price Performance

Eli Lilly CDR (CAD Hedged) (LLY) trades on Toronto Stock Exchange in CAD. The stock currently trades at CAD33.70, up 5.64% from the previous close.

Over the past year, LLY has traded between a low of CAD31.70 and a high of CAD40.33. The stock has lost 9.4% over this period. It is currently 16.4% below its 52-week high.

Eli Lilly CDR (CAD Hedged) has a market capitalization of $1.04T.

About Eli Lilly CDR (CAD Hedged)

Eli Lilly and Company is a pharmaceutical company that discovers, develops, and manufactures a wide range of medications and healthcare products. The company's core business is focused on the research, development, and commercialization of innovative medicines, including treatments for various diseases and conditions in areas such as oncology, diabetes, neuroscience, and immunology. Eli Lilly is a global leader in the pharmaceutical industry, with a diverse portfolio of products and a strong commitment to improving patient outcomes through scientific advancements.

Company Info

Sector: N/A
Industry: N/A
Exchange: Toronto Stock Exchange
Currency: CAD
Country: Canada

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: 1.35

Technical Indicators

52 Week High: CA$41.00
52 Week Low: CA$31.45
50 Day MA: CA$34.82
200 Day MA: N/A
Beta: N/A

Valuation

Trailing P/E: 37.53
Forward P/E: N/A
Price/Sales: N/A
Price/Book: 23.68
Enterprise Value: $1.04T